Model Number 3CX*FX25RWC |
Device Problem
Device Markings/Labelling Problem (2911)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/04/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11. h6: component code: 4739 - gas exchanger.Health effect - impact code: 2645 - no patient involvement.Health effect - clinical code: 4582 - no clinical, signs, symptoms or conditions.Medical device problem code: 2911 - device markings / labelling problem.Investigation findings: 3233 - results pending completion of investigation.Investigation conclusions: 11 - conclusion not yet available.
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during other - non clinical activity, the label details on the oxygenator were incomplete.As per the subsidiary, the defect was observed during incoming receipt, and it was not used in any product assembled.A single oxygenator was found within a larger shipment, for which the oxygenator label details were incomplete, missing information pertaining to the lot and use by date.No patient involvement.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on september 20, 2023.Upon further investigation of the reported event, the following information is new and/or changed: d4 (updated lot number); d9 (device availability - added date returned to manufacturer); g3 (date received by manufacturer) ; g6 (indication that this is a follow-up report) ; h2 (follow-up due to additional information) ; h3 (device evaluation anticipated by manufacturer - a second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Event Description
|
The oxygenator label details were incomplete.
|
|
Event Description
|
The oxygenator label details were incomplete.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added expiration date).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information and device evaluation).H3 (device evaluated by manufacturer).H4 (device manufacture date).H6 (identification of evaluation codes 10, 11, 3331, 154, 25).Type of investigation #1: 10 - testing of actual/suspected device.Type of investigation #2: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation #3: 3331 - analysis of production records.Investigation findings: 154 - inadequate labelling and/or instructions for use.Investigation conclusions: 25 - cause traced to manufacturing.The returned sample was inspected upon receipt and confirmed that the lot number and expiration date information were missing from the product label on the reservoir.A representative retention sample from the same lot number was inspected and confirmed to have all the required information on the product label.All capiox products are 100% visually inspected during the manufacturing and packaging process.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|
|